 has approved a new Alzheimer's drug. The new treatment by Eli Lilly will be sold under the brand name Kasunla and was approved Tuesday by the FDA after outside experts said the benefits of the drug outweighed the risk. The drug is designed to clear the brain of an Alzheimer's-related protein called beta-lactam.